Mayinglong Pharmaceutical Group Stock Co.,Ltd.’s Net Profit Rose 38% in First Quarter of 2023

Mayinglong Pharmaceutical Group Stock Co.,Ltd. (马应龙药业集团股份有限公司) (600993.SH) reported a net profit of 189.5 million yuan in the first quarter of 2023, up 38% year-on-year.

Meanwhile, the company posted 832.7 million yuan in revenue, down 12.3% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 25.5%.